|Description||GSK-189,254 is a H3 histamine receptor inverse agonist. It has subnanomolar affinity for the H3 receptor with Ki of 0.2nM. It possesses stimulant and nootropic effects and analgesic action suggesting a role for H3 receptors in pain processing in the spinal cord. No development was reported about Phase-II clinical trials for Narcolepsy in Europe.|
|B0084-459482||300 mg||$688||In stock|
|Solubility||Soluble in DMSO|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
|Current Developer||Originator GlaxoSmithKline|
Mebhydroline Napadisylate is an antihistamine used for symptomatic relief of allergic symptoms caused by histamine release, including nasal allergies and allerg...
Brompheniramine an antihistamine drug.It belongs to the propylamine class. It can be used for the treatment of the symptoms of the common cold and allergic rhin...
Tiprolisant is potent and selective nonimidazole inverse agonist at the histamine H3 receptor. (Ki=0.16 nM).
GSK-239512 is a histamine H3 receptor antagonist. In Jun 2015, Phase-II for Schizophrenia in USA was discontinued. Phase II clinical trilas for the treatment of...
Zolantidine dimaleate is a potent brain penetrating histamine H2 receptor antagonist.
The hydrochloride salt form of Dimaprit, which has been found to be a histamine H2 receptor agonist.
GS-283, an isoquinolin derivative, has been found to be histamine receptor and muscarinic receptor blocker.
The ditrifluoroacetate salt form of Carcinine, which is a highly selective histamine H3 receptor antagonist and could act as a natural antioxidant.